Genevieve Plu-Bureau

Summary

Country: France

Publications

  1. doi request reprint Hormonal contraceptives and venous thromboembolism: an epidemiological update
    Genevieve Plu-Bureau
    Department of Gynecology and Endocrinology, Hôpital Universitaires Paris Centre, Paris Descartes University, Paris, France
    Best Pract Res Clin Endocrinol Metab 27:25-34. 2013
  2. doi request reprint Hormonal contraceptives and arterial disease: an epidemiological update
    Genevieve Plu-Bureau
    Department of Gynecology and Endocrinology, Hôpital Universitaire Paris Centre, Paris Descartes University, Paris, France
    Best Pract Res Clin Endocrinol Metab 27:35-45. 2013
  3. doi request reprint Are we overestimating the stroke risk related to contraceptive pills?
    Anne Gompel
    Unité de gynécologie endocrinienne, Universite Paris Descartes, Hôpitaux Universitaires Paris Centre, APHP, Paris, France
    Curr Opin Neurol 27:29-34. 2014
  4. ncbi request reprint Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study
    Gregoire Le Gal
    Unit 258, Institut National de la Sante et de la Recherche Medicale, Paris, France
    Atherosclerosis 166:163-70. 2003
  5. ncbi request reprint Death-associated protein kinase loss of expression is a new marker for breast cancer prognosis
    Delphine Lévy
    Unité de gynécologie endocrinienne, Hopital Hotel Dieu, Paris, France
    Clin Cancer Res 10:3124-30. 2004
  6. doi request reprint Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis
    Zeina Chakhtoura
    Department of Gynecology and Endocrinology, Hopital Hotel Dieu, Assistance Publique Hopitaux de Paris, Paris Descartes University, 75004 Paris, France
    J Clin Endocrinol Metab 96:1169-74. 2011

Collaborators

Detail Information

Publications6

  1. doi request reprint Hormonal contraceptives and venous thromboembolism: an epidemiological update
    Genevieve Plu-Bureau
    Department of Gynecology and Endocrinology, Hôpital Universitaires Paris Centre, Paris Descartes University, Paris, France
    Best Pract Res Clin Endocrinol Metab 27:25-34. 2013
    ..In conclusion, newer generation formulations of hormonal contraceptives, as well as the non-oral hormonal contraceptive, seem to be more thrombogenic than second generation hormonal contraceptives...
  2. doi request reprint Hormonal contraceptives and arterial disease: an epidemiological update
    Genevieve Plu-Bureau
    Department of Gynecology and Endocrinology, Hôpital Universitaire Paris Centre, Paris Descartes University, Paris, France
    Best Pract Res Clin Endocrinol Metab 27:35-45. 2013
    ..23 for MI risk and 0.99 for ischemic stroke). In conclusion, newer generation formulations of COCs, as well as the non-oral hormonal contraceptive, do not seem to be safer than second generation hormonal contraceptives...
  3. doi request reprint Are we overestimating the stroke risk related to contraceptive pills?
    Anne Gompel
    Unité de gynécologie endocrinienne, Universite Paris Descartes, Hôpitaux Universitaires Paris Centre, APHP, Paris, France
    Curr Opin Neurol 27:29-34. 2014
    ..Given the benefits associated with combined hormonal contraceptives (COCs), it is important to properly evaluate their risks in order to provide a better benefit/risk balance to young women...
  4. ncbi request reprint Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study
    Gregoire Le Gal
    Unit 258, Institut National de la Sante et de la Recherche Medicale, Paris, France
    Atherosclerosis 166:163-70. 2003
    ..Information on the impact of hormone replacement therapy (HRT) on carotid atherosclerosis is limited. Moreover, transdermal estrogens have not been investigated...
  5. ncbi request reprint Death-associated protein kinase loss of expression is a new marker for breast cancer prognosis
    Delphine Lévy
    Unité de gynécologie endocrinienne, Hopital Hotel Dieu, Paris, France
    Clin Cancer Res 10:3124-30. 2004
    ..We analyzed the level of DAP-kinase expression in breast cancer specimens and its correlation with survival...
  6. doi request reprint Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis
    Zeina Chakhtoura
    Department of Gynecology and Endocrinology, Hopital Hotel Dieu, Assistance Publique Hopitaux de Paris, Paris Descartes University, 75004 Paris, France
    J Clin Endocrinol Metab 96:1169-74. 2011
    ..While progestogen-only contraceptives (POC) are commonly used worldwide, their impact on cardiovascular diseases is poorly investigated and remains unclear...